Full Text
Budget Impact Model of Sunitinib as First Line Treatment of Metastatic Renal Cell Carcinoma in China

Abstract

Authors

X Wu Q Shi Y Huang H Yin M Li S Patel Y Wu

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×